Anti-oxLDL IgM antibodies
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-oxLDL IgM antibodies, covering 2016-03-15 to 2016-03-15. Get the full timeline:
Most recent: Clinical Trial Update: Anti-oxLDL IgM Antibodies as a Novel Therapy for Metabolic Lipid Diseases [EARLY_Phase 1]